EUVIMEDEUVIMED entdecken
Crossref

Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020

Alyssa R Golden iD, Heather J Adam, James A Karlowsky, Melanie Baxter, John Schellenberg, Irene Martin, Walter Demczuk, Jessica Minion, Paul Van Caeseele, Julianne V Kus, Allison McGeer, Brigitte Lefebvre und 6 weitere

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Alyssa R Golden und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3R2, Canada. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: University of Manitoba; Shared Health, National Microbiology Laboratory—Public Health Agency of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the lineages and genomic antimicrobial resistance (AMR) determinants of the 10 most common pneumococcal serotypes identified in Canada during the five most recent years of the SAVE study, in the context of the 10-year post-PCV13 period in Canada.

Methods

The 10 most common invasive Streptococcus pneumoniae serotypes collected by the SAVE study from 2016 to 2020 were 3, 22F, 9N, 8, 4, 12F, 19A, 33F, 23A and 15A. A random sample comprising ∼5% of each of these serotypes collected during each year of the full SAVE study (2011–2020) were selected for whole-genome sequencing (WGS) using the Illumina NextSeq platform. Phylogenomic analysis was performed using the SNVPhyl pipeline. WGS data were used to identify virulence genes of interest, sequence types, global pneumococcal sequence clusters (GPSC) and AMR determinants.

Results

Of the 10 serotypes analysed in this study, six increased significantly in prevalence from 2011 to 2020: 3, 4, 8, 9N, 23A and 33F (P ≤ 0.0201). Serotypes 12F and 15A remained stable in prevalence over time, while serotype 19A decreased in prevalence (P < 0.0001). The investigated serotypes represented four of the most prevalent international lineages causing non-vaccine serotype pneumococcal disease in the PCV13 era: GPSC3 (serotypes 8/33F), GPSC19 (22F), GPSC5 (23A) and GPSC26 (12F). Of these lineages, GPSC5 isolates were found to consistently possess the most AMR determinants. Commonly collected vaccine serotypes 3 and 4 were associated with GPSC12 and GPSC27, respectively. However, a more recently collected lineage of serotype 4 (GPSC192) was highly clonal and possessed AMR determinants.

Conclusions

Continued genomic surveillance of S. pneumoniae in Canada is essential to monitor for the appearance of new and evolving lineages, including antimicrobial-resistant GPSC5 and GPSC162.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal InfectionsHumansSerogroupGenomicsCanadaPhylogenyPneumococcal Vaccines

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3R2, Canada.
  • Clinical Microbiology, Shared Health, MS673-820 Sherbrook Street, Winnipeg, Manitoba, R3A 1R9, Canada.
  • Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, R3E 0J9, Canada.
  • Roy Romanow Provincial Laboratory, Saskatchewan Health Authority, 5 Research Drive, Regina, Saskatchewan, S4S 0A4, Canada.
  • Cadham Provincial Laboratory, Shared Health, 750 William Avenue, Winnipeg, Manitoba, R3E 3J7, Canada.
  • Public Health Ontario Laboratory, 661 University Avenue, Toronto, Ontario, M5G 1M1, Canada.

ORCID-Profile: Alyssa R Golden

Förderung

  • University of Manitoba; Shared Health
  • National Microbiology Laboratory—Public Health Agency of Canada

Zitieren

APA

Golden, A. R., Adam, H. J., Karlowsky, J. A., Baxter, M., Schellenberg, J., Martin, I., Demczuk, W., Minion, J., Van Caeseele, P., Kus, J. V., McGeer, A., Lefebvre, B., Smadi, H., Haldane, D., Yu, Y., Mead, K., Mulvey, M. R., & Zhanel, G. G. (2023). Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad067

Vancouver

Golden AR, Adam HJ, Karlowsky JA, Baxter M, Schellenberg J, Martin I, et al. Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad067

BibTeX
@article{Golden2023,
  author = {Golden, Alyssa R and Adam, Heather J and Karlowsky, James A and Baxter, Melanie and Schellenberg, John and Martin, Irene and Demczuk, Walter and Minion, Jessica and Van Caeseele, Paul and Kus, Julianne V and McGeer, Allison and Lefebvre, Brigitte and Smadi, Hanan and Haldane, David and Yu, Yang and Mead, Kristen and Mulvey, Michael R and Zhanel, George G},
  title = {Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad067}
}
Kostenlos starten →